Appendix 1A — ASX Listing Application and Agreement is required by listing rule 1.7 to be used by an entity seeking admission to the official list as an ASX Listing.
View Appendix 1A — ASX Listing Application and Agreement.
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway
September 9, 2025
Highlights Dr Nina Webster appointed as IBX Non-Executive Director, bringing significant clinical development expertise and corporate experienceto the IBX Board ahead of HER2 Breast cancer